BEN vs KYTX · P/E 36, rev $8.77B vs $488.8M cap
Franklin Resources Inc (BEN) versus Kyverna Therapeutics, Inc. Common Stock (KYTX) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
KYTX does not have a complete income-statement cache yet.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. KYTX currently screens at market cap $488.8M.
Not investment advice. Open the BEN and KYTX stock pages for the full models.
Not investment advice.